| Adenosine amine congener mitigates noise-induced cochlear injury. | |
| | |
MedLine Citation:
|
PMID: 20806018 Owner: NLM Status: PubMed-not-MEDLINE |
Abstract/OtherAbstract:
|
Hearing loss from noise exposure is a leading occupational disease, with up to 5% of the population at risk world-wide. Here, we present a novel purine-based pharmacological intervention that can ameliorate noise-induced cochlear injury. Wistar rats were exposed to narrow-band noise (8-12 kHz, 110 dB SPL, 2-24 h) to induce cochlear damage and permanent hearing loss. The selective adenosine A(1) receptor agonist, adenosine amine congener (ADAC), was administered intraperitoneally (100 microg/kg/day) at time intervals after noise exposure. Hearing thresholds were assessed using auditory brainstem responses and the hair cell loss was evaluated by quantitative histology. Free radical damage in the organ of Corti was assessed using nitrotyrosine immunohistochemistry. The treatment with ADAC after noise exposure led to a significantly greater recovery of hearing thresholds compared with controls. These results were upheld by increased survival of sensory hair cells and reduced nitrotyrosine immunoreactivity in ADAC-treated cochlea. We propose that ADAC could be a valuable treatment for noise-induced cochlear injury in instances of both acute and extended noise exposures. |
| | |
Authors:
|
Srdjan M Vlajkovic; Kyu-Hyun Lee; Ann Chi Yan Wong; Cindy X Guo; Rita Gupta; Gary D Housley; Peter R Thorne |
Related Documents
:
|
19450428 - The effects of acoustic environment after traumatic noise exposure on hearing and outer... 11255218 - Gsm phone signal does not produce subjective symptoms. 1006458 - Music, noise and hearing damage. 7776268 - Stiffness changes in chick hair bundles following in vitro overstimulation. 15957768 - Level dependence of distortion-product otoacoustic emissions measured at high frequenci... 21556808 - Assimilation and contrast: the two sides of specific interference between action and pe... |
Publication Detail:
|
Type: Journal Article Date: 2010-06-30 |
Journal Detail:
|
Title: Purinergic signalling Volume: 6 ISSN: 1573-9546 ISO Abbreviation: Purinergic Signal. Publication Date: 2010 Jun |
Date Detail:
|
Created Date: 2010-08-31 Completed Date: 2011-07-14 Revised Date: 2011-08-09 |
Medline Journal Info:
|
Nlm Unique ID: 101250499 Medline TA: Purinergic Signal Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 273-81 Citation Subset: - |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
| Grant Support | |
ID/Acronym/Agency:
|
G29//Action on Hearing Loss |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Reduced P2x(2) receptor-mediated regulation of endocochlear potential in the ageing mouse cochlea.
Next Document: Regarding managing erotic and eroticized transference.